Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madeleine V Pahl

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Glomerular Diseases|October 30, 2023
Fabry Disease Presenting as End-Stage Kidney DiseaseMadeleine V Pahl, Jean Hou
Seminars in Dialysis|April 10, 2015
The Chronic Kidney Disease - Colonic AxisMadeleine V Pahl, Nosratola D Vaziri
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 18, 2015
Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatmentNosratola D Vaziri, Ying-Yong Zhao, Madeleine V Pahl
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|October 4, 2005
Boron and the kidneyMadeleine V Pahl, B Dwight Culver, Nosratola D Vaziri
Translational Research : the Journal of Laboratory and Clinical Medicine|January 14, 2009
Impaired antioxidant activity of high-density lipoprotein in chronic kidney diseaseHamid Moradi, Madeleine V Pahl, Reza Elahimehr, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|December 28, 2011
Effect of uremia on structure and function of immune systemNosratola D Vaziri, Madeleine V Pahl, Albert Crum, et al.
Journal of the National Medical Association|April 29, 2009
Antioxidant therapy does not ameliorate oxidative stress and inflammation in patients with end-stage renal diseaseMohammad Kamgar, Frank Zaldivar, Nosratola D Vaziri, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2009
Upregulation of monocyte/macrophage HGFIN (Gpnmb/Osteoactivin) expression in end-stage renal diseaseMadeleine V Pahl, Nosratola D Vaziri, Jun Yuan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 20, 2009
Plasma phospholipid transfer protein, cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase in end-stage renal disease (ESRD)Madeleine V Pahl, Zhenmin Ni, Lili Sepassi, et al.
Journal of Renal Care|December 23, 2017
The effect of the interdialytic interval on cognitive function in patients on haemodialysisShayna L Henry, Larry D Jamner, Sarah E Choi, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Glomerular Diseases|October 30, 2023
Fabry Disease Presenting as End-Stage Kidney DiseaseMadeleine V Pahl, Jean Hou
Seminars in Dialysis|April 10, 2015
The Chronic Kidney Disease - Colonic AxisMadeleine V Pahl, Nosratola D Vaziri
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 18, 2015
Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatmentNosratola D Vaziri, Ying-Yong Zhao, Madeleine V Pahl
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|October 4, 2005
Boron and the kidneyMadeleine V Pahl, B Dwight Culver, Nosratola D Vaziri
Translational Research : the Journal of Laboratory and Clinical Medicine|January 14, 2009
Impaired antioxidant activity of high-density lipoprotein in chronic kidney diseaseHamid Moradi, Madeleine V Pahl, Reza Elahimehr, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|December 28, 2011
Effect of uremia on structure and function of immune systemNosratola D Vaziri, Madeleine V Pahl, Albert Crum, et al.
Journal of the National Medical Association|April 29, 2009
Antioxidant therapy does not ameliorate oxidative stress and inflammation in patients with end-stage renal diseaseMohammad Kamgar, Frank Zaldivar, Nosratola D Vaziri, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2009
Upregulation of monocyte/macrophage HGFIN (Gpnmb/Osteoactivin) expression in end-stage renal diseaseMadeleine V Pahl, Nosratola D Vaziri, Jun Yuan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 20, 2009
Plasma phospholipid transfer protein, cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase in end-stage renal disease (ESRD)Madeleine V Pahl, Zhenmin Ni, Lili Sepassi, et al.
Journal of Renal Care|December 23, 2017
The effect of the interdialytic interval on cognitive function in patients on haemodialysisShayna L Henry, Larry D Jamner, Sarah E Choi, et al.
Pageof 3